Previous Page  17 / 27 Next Page
Information
Show Menu
Previous Page 17 / 27 Next Page
Page Background

Page 46

Notes:

allied

academies

August 27-28, 2018 | London, UK

International Conference on

Healthcare and Health Management

Cardiology and Cardiac Surgery

Joint Event

&

Journal of Public Health Policy and Planning | Volume: 2

21

st

Century Approach – No average patient: A Noninvasive measuring of drug sensitivity

Maria Kuman

Holistic Research Institute, USA

C

linical research shows that humans have different: drug,

stress, and emotional sensitivity. Usually, the drug-sensitive

individuals are also stress sensitive and emotionally sensitive.

If so, there is no such a thing as an average patient. The dose

for a low-sensitive patient would almost kill the high-sensitive

one by triggering a bouquet of allergic reactions. The presently

existing method for testing drug tolerance (Boston University

School of Medicine) requires ingesting of the drug, which

means the intolerance is detected after the harm is done.

The Holiner’s test of genetic testing is complicated, time

consuming, and does not have the accuracy of our method.

Sensitivity could be measured with the amount of released

neurotransmitters, but this would require blood drawing.

Since the neurotransmitters are electrically charged, we

offer electrical measurements with our sensitive patented

equipment to measure the drug, stress and emotional

sensitivity of patients. The drug tolerance can be tested when

the drug is prescribed; it does not require ingestion, it is fast,

and it is non-invasive. Based on measurements, the patients

would be divided into three basic groups: low, middle, and high

sensitivity and each group would be drug-treated differently.

This article also explains why the mathematical description

of sensitivity would require nonlinear quantum mechanics.

e

:

holisticare@mariakuman.com